| Literature DB >> 32157302 |
Arianna Troilo1, Claudia Wehr2, Iga Janowska1, Nils Venhoff1, Jens Thiel1, Justyna Rawluk2, Natalie Frede1, Julian Staniek1,3, Raquel Lorenzetti1, Marei-Theresa Schleyer1, Georg W Herget4, Lukas Konstantinidis4, Miriam Erlacher5, Michele Proietti6, Nadezhda Camacho-Ordonez6, Reinhard Edmund Voll1, Bodo Grimbacher6,7,8,9, Klaus Warnatz1,6, Ulrich Salzer1, Marta Rizzi1,10.
Abstract
Common variable immunodeficiency (CVID) is a disease characterized by increased susceptibility to infections, hypogammaglobulinemia, and immune dysregulation. Although CVID is thought to be a disorder of the peripheral B-cell compartment, in 25% of patients, early B-cell development in the bone marrow is impaired. Because poor B-cell reconstitution after hematopoietic stem cell transplantation has been observed, we hypothesized that in some patients the bone marrow environment is not permissive to B-cell development. Studying the differentiation dynamics of bone marrow-derived CD34+ cells into immature B cells in vitro allowed us to distinguish patients with B-cell intrinsic defects and patients with a nonpermissive bone marrow environment. In the former, immature B cells did not develop and in the latter CD34+ cells differentiated into immature cells in vitro, but less efficiently in vivo. In a further group of patients, the uncommitted precursors were unable to support the constant development of B cells in vitro, indicating a possible low frequency or exhaustion of the precursor population. Hematopoietic stem cell transplantation would result in normal B-cell repopulation in case of intrinsic B-cell defect, but in defective B-cell repopulation in a nonpermissive environment. Our study points to the importance of the bone marrow niche in the pathogenesis of CVID.Entities:
Mesh:
Year: 2020 PMID: 32157302 PMCID: PMC7195542 DOI: 10.1182/blood.2019003855
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113